Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroids for septic shock: back from the dead? (Pro).

Robert A Balk1

  • 1Section of Pulmonary and Critical Care Medicine, Department of Medicine, Rush Medical College and Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA. Robert_A_Balk@rsh.net

Chest
|May 13, 2003
PubMed
Summary

Corticosteroid therapy for severe sepsis and septic shock remains controversial. Recent studies suggest physiologic steroid replacement may benefit patients with vasopressor-dependent septic shock, potentially re-establishing its role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Performance of Point-of-Care Immunoassay Measurements of Pancreatic Stone Protein for Sepsis Detection in ICU Patients: A Prospective, Multicenter, Biomarker-Blinded Study.

Critical care medicine·2026
Same author

Major Publications in the Critical Care Pharmacotherapy Literature: 2023.

Critical care explorations·2024
Same author

Association between Dexmedetomidine Use and Mortality in Patients with COVID-19 Receiving Invasive Mechanical Ventilation: A U.S. National COVID Cohort Collaborative (N3C) Study.

Journal of clinical medicine·2024
Same author

The Role of Biomarkers in the Diagnosis and Management of Pneumonia.

Infectious disease clinics of North America·2024
Same author

Executive Summary: Guidelines on Use of Corticosteroids in Critically Ill Patients With Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia Focused Update 2024.

Critical care medicine·2024
Same author

2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia.

Critical care medicine·2024

Area of Science:

  • Critical Care Medicine
  • Endocrinology
  • Pharmacology

Background:

  • Corticosteroids as adjunctive therapy for severe sepsis and septic shock have been debated for over 35 years.
  • Preclinical data suggest benefits, but human sepsis data have been less convincing, with some studies indicating potential harm from early high-dose use.
  • The concept of relative adrenal insufficiency in sepsis adds complexity to treatment decisions.

Purpose of the Study:

  • To review the evolving role of corticosteroid therapy in managing severe sepsis and septic shock.
  • To evaluate recent evidence supporting the use of physiologic steroid replacement in specific septic shock populations.
  • To discuss the implications of relative adrenal insufficiency on corticosteroid treatment strategies.

Main Methods:

Related Experiment Videos

  • Review of preclinical and clinical trial data on corticosteroid use in sepsis.
  • Analysis of recent studies focusing on hemodynamic and survival outcomes.
  • Consideration of the pathophysiology of relative adrenal insufficiency in severe sepsis.

    • Main Results:

    • Recent trials indicate hemodynamic and survival benefits with physiologic steroid replacement in vasopressor-dependent septic shock.
    • These findings contrast with earlier concerns about high-dose corticosteroid administration.
    • Relative adrenal insufficiency is increasingly recognized in severe sepsis patients.

    Conclusions:

    • Physiologic corticosteroid replacement therapy shows promise in specific subsets of patients with septic shock.
    • The recognition of relative adrenal insufficiency may support a defined role for corticosteroids in severe sepsis management.
    • Further research is needed to optimize corticosteroid use in sepsis.